Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc ...

Genflow's lead compound, GF-1002, works through the delivery of a centenarian variant of the SIRT6 gene which has yielded promising preclinical results.

Genflow's 12-month proof-of-concept clinical trial evaluating their SIRT6-centenarian gene therapy in aged dogs began in March 2025. Other programs planned for 2025, include a clinical trial that will ...

Hollywood's Golden Age was an unforgettable time in the entertainment industry, as it gave rise to many renowned movie stars.

Lee Calvert sits in her new bedroom in Bonny Doon, Calif. She moved to an accessory dwelling unit on her daughter’s property ...

Humanity’s pursuit of longer life is moving from fiction to something far more real. At the heart of this shift is a bold ...

A new DNA test can predict how well you're aging—and how long you might live. Scientists say it could change the future of ...

Centenarians (greater than 100 years of age) provide a unique lens through which to study longevity and healthy aging as they have the capacity to delay or escape aging-related diseases such as ...